Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Saved in:
| Title: | Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. |
|---|---|
| Authors: | Bechman K; Department of Inflammation Biology, School of Immunology & Microbial Sciences., Clarke BD; Department of Inflammation Biology, School of Immunology & Microbial Sciences., Rutherford AI; Department of Inflammation Biology, School of Immunology & Microbial Sciences., Yates M; Department of Inflammation Biology, School of Immunology & Microbial Sciences., Nikiphorou E; Department of Inflammation Biology, School of Immunology & Microbial Sciences., Molokhia M; Primary Care & Public Health Sciences, Health & Social Care Research, Kings College London, London., Norton S; Department of Inflammation Biology, School of Immunology & Microbial Sciences., Cope AP; Department of Inflammation Biology, School of Immunology & Microbial Sciences., Hyrich KL; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, University of Manchester.; NIHR Manchester Biomedical Research Centre, Manchester Foundation Trust, Manchester, UK., Galloway JB; Department of Inflammation Biology, School of Immunology & Microbial Sciences. |
| Source: | Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2019 Oct 01; Vol. 58 (10), pp. 1767-1776. |
| Publication Type: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
